Xiangxue Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Market Capitalization	4,774	6,018	6,461	3,406	3,961	5,266
Market Cap Growth	-13.43%	-6.86%	89.71%	-14.02%	-24.79%	-9.85%
Enterprise Value	6,454	8,515	9,128	6,159	6,816	9,064
Last Close Price	7.22	9.10	9.77	5.15	6.07	8.07
Forward PE	-	11.93	11.93	11.93	11.93	11.93
PS Ratio	3.12	3.77	3.48	1.48	1.81	1.77
PB Ratio	-56.78	136.93	4.49	1.47	1.46	1.40
P/TBV Ratio	-	-	437.03	4.23	3.47	3.20
P/FCF Ratio	35.08	50.95	-	16.42	-	-
P/OCF Ratio	30.59	43.10	355.48	12.93	17.42	20.45
EV/Sales Ratio	4.22	5.34	4.91	2.68	3.12	3.05
EV/EBITDA Ratio	56.12	97.14	-	21.82	113.06	72.50
EV/EBIT Ratio	-	-	-	123.98	-	-
EV/FCF Ratio	47.42	72.09	-	29.69	-	-
Debt / Equity Ratio	-17.09	33.38	1.56	1.05	0.90	0.92
Debt / EBITDA Ratio	12.50	15.96	-	8.48	38.38	27.04
Debt / FCF Ratio	10.56	12.42	-	11.73	-	-
Net Debt / Equity Ratio	-15.37	27.59	1.46	0.99	0.84	0.82
Net Debt / EBITDA Ratio	11.67	13.83	-163.18	8.09	38.01	24.64
Net Debt / FCF Ratio	9.50	10.26	-122.94	11.01	-16.38	-10.10
Asset Turnover	0.22	0.22	0.24	0.27	0.22	0.25
Inventory Turnover	3.41	3.69	3.86	3.54	2.69	2.78
Quick Ratio	0.16	0.18	0.19	0.19	0.18	0.28
Current Ratio	0.24	0.26	0.30	0.35	0.32	0.44
Return on Equity (ROE)	-217.95%	-184.89%	-45.91%	-15.96%	-15.58%	-16.45%
Return on Assets (ROA)	-0.63%	-0.90%	-1.85%	0.37%	-1.09%	-0.12%
Return on Invested Capital (ROIC)	-10.67%	-4.26%	-5.75%	1.03%	-2.96%	-0.31%
Return on Capital Employed (ROCE)	-92.60%	-17.80%	-11.10%	1.60%	-5.10%	-0.50%
Earnings Yield	-29.66%	-23.14%	-13.29%	-11.42%	-13.38%	-13.07%
FCF Yield	2.85%	1.96%	-0.26%	6.09%	-3.53%	-5.79%
Buyback Yield / Dilution	-0.63%	0.10%	-0.18%	0.50%	-0.09%	-0.89%
Total Shareholder Return	-0.63%	0.10%	-0.18%	0.50%	-0.09%	-0.89%